Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -481,998
▼ 248% vs 2024
Profit
Caution€ -462,336
▼ 617% vs 2024
Debts
Low€ 123,784
▲ 410% vs 2024
BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY from Jette, company number BE0439302013, closed financial year 2025 with a result of € -462,336 after tax. For that financial year BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY recorded a gross margin of € -481,998 and equity of € 771,668. Compared with financial year 2024, the result moved from € -64,484 to € -462,336. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
What happened at BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY?
What happened at BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 462,336. Source: NBB ↗
- Daniel Klink became a director. NBB
- Elise Nauwynck became a director. NBB
- Philippe Lysy stepped down as director. NBB
- Marianne Becker stepped down as director. NBB
- Start of the company according to the CBE. KBO
In short
From € 120,966 profit in 2021 to € 462,336 loss in 2025.
Paid € 26,536 in corporate taxes since 2021.
Best year ever: 2021, with € 120,966 profit.
A new publication or filing at BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY? We notify you, reason included.
Follow BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGYNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY are Jean De Schepper, Daniel Klink and Elise Nauwynck. The same people are also behind KLINK MEDICAL SERVICES.
Directors
According to the 2025 annual accounts
Jean De Schepper
Director
since 2025
Elise Nauwynck
Director
since 2025
Philippe Lysy
Director
· until 2025
Marianne Becker
Director
· until 2025
Establishments
Establishment units
Physical locations of this company
Laarbeeklaan 101
1090 Jette
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
Belgische Vereniging voor Orthopedie en Traumatologie
BELGISCH HOOFDPIJNGENOOTSCHAP
The Toxicological Society of Belgium and Luxembourg
belgian society of pediatric gastroenterology hepatology and nutrition
Belgian Diabetes Registry
+16 more
Details
- Company number
- 0439.302.013
- VAT number
- BE 0439.302.013
- Registered office
- Laarbeeklaan 101, 1090 Jette
- Names & denominations
- BELGIAN SOCIETY FOR PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY · Belgian and Luxemburgish Society for Pediatric Endocrinology and Diabetology · BELSPEED
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 28 February 1989
- Peppol
- Active · Active since 22 Nov 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.